Traci L. Bricker

3.9k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Traci L. Bricker is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Traci L. Bricker has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Traci L. Bricker's work include SARS-CoV-2 and COVID-19 Research (10 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Traci L. Bricker is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (5 papers). Traci L. Bricker collaborates with scholars based in United States, Ukraine and Japan. Traci L. Bricker's co-authors include Jonathan M. Green, Jonathan Boomer, Osamu Takasu, Stephen Jarman, Paul E. Swanson, Richard S. Hotchkiss, Andrew H. Walton, Alexander S. Krupnick, Kathleen To and Kathy Chang and has published in prestigious journals such as JAMA, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Traci L. Bricker

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

2011 1.3k citations Jonathan Boomer, Kathleen To et al. profile →

Peers

Countries citing papers authored by Traci L. Bricker

Since Specialization

Citations

This map shows the geographic impact of Traci L. Bricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Traci L. Bricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Traci L. Bricker more than expected).

Fields of papers citing papers by Traci L. Bricker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Traci L. Bricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Traci L. Bricker. The network helps show where Traci L. Bricker may publish in the future.

Co-authorship network of co-authors of Traci L. Bricker

This figure shows the co-authorship network connecting the top 25 collaborators of Traci L. Bricker. A scholar is included among the top collaborators of Traci L. Bricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Traci L. Bricker. Traci L. Bricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Matthew Mahoney, (unknown), (unknown), Elizabeth Weiland, (unknown), Zhenfu Han, Traci L. Bricker, Michael A. Tartell, Sean P. J. Whelan, Adrianus C. M. Boon, James W. Janetka	0
2	Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters 2024 ·Journal of Virology ·Traci L. Bricker, Astha Joshi, Nadia Soudani, Suzanne M. Scheaffer, Nita Patel, Mimi Guebre‐Xabier, Gale Smith, Michael Diamond, Adrianus C. M. Boon	4
3	Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19 2024 ·Journal of Virology ·Adrianus C. M. Boon, Traci L. Bricker, Ethan J. Fritch, Sarah R. Leist, Kendra L. Gully, Ralph S. Baric, Rachel L. Graham, (unknown), Matthew Mahoney, James W. Janetka	8
4	Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection 2024 ·Nature Immunology ·Baoling Ying, Tamarand L. Darling, Pritesh Desai, Chieh-Yu Liang, Igor P. Dmitriev, Nadia Soudani, Traci L. Bricker, Elena A. Kashentseva, Houda Harastani, Saravanan Raju, Meizi Liu, Aaron G. Schmidt, David T. Curiel, Adrianus C. M. Boon, Michael Diamond	18
5	Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters 2024 ·Journal of Virology ·Nadia Soudani, Traci L. Bricker, Tamarand L. Darling, (unknown), Nita Patel, (unknown), Gale Smith, Meredith E. Davis-Gardner, (unknown), Ali H. Ellebedy, Adrianus C. M. Boon	2
6	Real-time environmental surveillance of SARS-CoV-2 aerosols 2023 ·Nature Communications ·Joseph V. Puthussery, (unknown), (unknown), (unknown), Benjamin J. Sumlin, (unknown), (unknown), Nishit Shetty, (unknown), (unknown), David L. Brody, Thomas J. Esparza, Traci L. Bricker, Adrianus C. M. Boon, Carla M. Yuede, John R. Cirrito, Rajan K. Chakrabarty	30
7	The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2 2023 ·Journal of Virology ·Hongbing Jiang, Astha Joshi, (unknown), Andrew B. Janowski, (unknown), Traci L. Bricker, Tamarand L. Darling, Houda Harastani, (unknown), Hongwei Chen, Stephen Tahan, (unknown), (unknown), Joshua Blatter, Scott A. Handley, Bijal A. Parikh, David Wang, Adrianus C. M. Boon	8
8	Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care 2023 ·ACS Sensors ·(unknown), Nishit Shetty, (unknown), Joseph V. Puthussery, Benjamin J. Sumlin, (unknown), (unknown), (unknown), David L. Brody, Thomas J. Esparza, Jane A. O’Halloran, Rachel M. Presti, Traci L. Bricker, Adrianus C. M. Boon, Carla M. Yuede, John R. Cirrito, Rajan K. Chakrabarty	15
9	Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters 2023 ·Journal of Virology ·James Brett Case, Suzanne M. Scheaffer, Tamarand L. Darling, Traci L. Bricker, Lucas J. Adams, Houda Harastani, (unknown), Shilpa Sanapala, Daved H. Fremont, Adrianus C. M. Boon, Michael Diamond	10
10	mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2 2022 ·Med ·Tamarand L. Darling, Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Traci L. Bricker, Chieh-Yu Liang, Astha Joshi, (unknown), (unknown), Aaron J. Schmitz, Peter Halfmann, Yoshihiro Kawaoka, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond, Adrianus C. M. Boon	6
11	A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters 2021 ·Cell Reports ·Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Houda Harastani, Allison Soung, Xiaoping Jiang, Ya-Nan Dai, Haiyan Zhao, Lucas J. Adams, Michael J. Holtzman, Adam L. Bailey, James Brett Case, Daved H. Fremont, Robyn S. Klein, Michael Diamond, Adrianus C. M. Boon	102
12	Therapeutic efficacy of favipiravir against Bourbon virus in mice 2019 ·PLoS Pathogens ·Traci L. Bricker, (unknown), Anshu P. Gounder, Andrew B. Janowski, Guoyan Zhao, Graham D. Williams, Brett W. Jagger, Michael Diamond, Thomas C. Bailey, Jennie H. Kwon, David Wang, Adrianus C. M. Boon	30
13	Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer 2018 ·PLoS Pathogens ·Anshu P. Gounder, Christine C. Yokoyama, Nicholas N. Jarjour, Traci L. Bricker, Brian T. Edelson, Adrianus C. M. Boon	22
14	Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice 2016 ·Virology ·(unknown), Rita E. Chen, Anshu P. Gounder, Amelia K. Pinto, Traci L. Bricker, (unknown), (unknown), Graham D. Williams, Richard J. Webby, Adrianus C. M. Boon	15
15	Cutting Edge: A Double-Mutant Knockin of the CD28 YMNM and PYAP Motifs Reveals a Critical Role for the YMNM Motif in Regulation of T Cell Proliferation and Bcl-xL Expression 2014 ·The Journal of Immunology ·Jonathan Boomer, Christine Deppong, (unknown), Traci L. Bricker, Jonathan M. Green	16
16	Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure 2012 ·Survey of Anesthesiology ·Jonathan Boomer, Kathleen To, Kathy Chang, Osamu Takasu, Dale F. Osborne, Andrew H. Walton, Traci L. Bricker, Stephen Jarman, Daniel Kreisel, Alexander S. Krupnick, Anil Srivastava, Paul E. Swanson, Jonathan M. Green, Richard S. Hotchkiss	134
17	CTLA4‐Ig inhibits allergic airway inflammation by a novel CD28‐independent, nitric oxide synthase‐dependent mechanism 2010 ·European Journal of Immunology ·Christine Deppong, Amit Parulekar, Jonathan Boomer, Traci L. Bricker, Jonathan M. Green	14
18	Targeted Knock-In Mice Expressing Mutations of CD28 Reveal an Essential Pathway for Costimulation 2009 ·Molecular and Cellular Biology ·(unknown), Jonathan Boomer, Christine Deppong, (unknown), Julia Sim, Traci L. Bricker, John H. Russell, Jonathan M. Green	63
19	A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant 2006 ·The Journal of Experimental Medicine ·(unknown), (unknown), Christine Deppong, Joseph Lin, Traci L. Bricker, Twyla Juehne, (unknown), Jonathan M. Green	52
20	Cutting Edge: B and T Lymphocyte Attenuator and Programmed Death Receptor-1 Inhibitory Receptors Are Required for Termination of Acute Allergic Airway Inflammation 2006 ·The Journal of Immunology ·Christine Deppong, Twyla Juehne, Michelle A. Hurchla, (unknown), (unknown), (unknown), Traci L. Bricker, Laurie P. Shornick, Erika C. Crouch, Theresa L. Murphy, Michael J. Holtzman, Kenneth M. Murphy, Jonathan M. Green	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact